SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bliss GVS Pharma to divest step down subsidiary

12 Jan 2018 Evaluate

Bliss GVS Pharma has decided to divest the step down subsidiary of the company, Bliss GVS Healthcare, Nairobi. This decision has been made essentially to lower dependence on Tender Driven Managed Healthcare business and focus on growing the Pharmaceuticals Business. The Board of the Company at their meeting held on January 11, 2018, considered the same.

Bliss GVS Pharma is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market.

Bliss GVS Pharma Share Price

269.35 -2.55 (-0.94%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×